About
Ension, Inc. is a medical device incubator that provides product development services, biocompatible surface modification, extracellular matrix and regenerative medicine scaffolds, and blood testing expertise. Ension, Inc was founded by Drs. Philip Litwak and Mark Gartner in 2001 to pursue design and development of novel medical technologies. The Company has expanded its infrastructure to include biocompatible surface design and biomaterial modification and testing as well as regenerative product development.
Technologies
Mobile FriendlyGoogle AnalyticsApacheRemoteCircle
Keywords
regenerative medicine scaffoldsecmocollagen processing & crosslinkingmedical device product developmentwound dressings & hemostatsbiocompatible surfacesbiologics immobilizationcardiac & respiratory devicesbioactive heparin surfacesbiologic scaffoldsmedical devicesregulatory complianceantithrombogenic surfacesimplantable biomaterialshealthcare equipment & suppliesbioactive surface technology patentblood-material interface optimizationmedical equipment and supplies manufacturingblood-contacting device coatingsbiomaterial modificationmedical technologycollagen matrix scaffoldsvascular prosthesesbiomolecule immobilizationblood clot prevention surfacesbiotechnologymedical device surfacescgmp pilot manufacturingmedical device coatinggovernment
Company Information
- Employees7
- Founded2001
- Annual Revenue$7765000
Location
240 William Pitt Way, Pittsburgh, Pennsylvania, United States, 15238
